Do We Need Anthracyclines for Elderly Patients with Triple-Negative Breast Cancer?
In our retrospective analysis of SUCCESS A and C trial, the use of AF chemotherapy in elderly patients with TNBC was associated with similar survival rates but less toxicity compared to AB chemotherapy. Further randomized controlled trials with AF regimen focusing on elderly patients with TNBC are necessary to confirm our results.
Authors
- Davut Dayan (ORCID: https://orcid.org/0000-0003-1589-2016)
- Franziska Mergel
- Brigitte Rack (ORCID: https://orcid.org/0000-0002-7539-4839)
- Elena Leinert (ORCID: https://orcid.org/0000-0001-5795-3417)
- Sabine Heublein (ORCID: https://orcid.org/0000-0002-5326-0186)
- Thomas W. P. Friedl (ORCID: https://orcid.org/0000-0002-4773-8067)
- Stefan Lukac (ORCID: https://orcid.org/0000-0002-9336-2267)
- Henning Schäffler
- Kerstin Pfister (ORCID: https://orcid.org/0009-0002-2831-1401)
- Visnja Fink
- Wolfgang Janni
Institutions
- University Hospital Ulm (DE)
Publication Details
- Journal
- Breast Care
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1159/000544906
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94